CELU — Celularity Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Celularity, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-2.63	-100	14.2	-196	-57.9
Depreciation
Deferred Taxes
Non-Cash Items	-1.78	-6.36	-144	145	21.4
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	3.23	-11.1	-18	3.25	22.2
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-1.18	-110	-138	-38.7	-6.4
Capital Expenditures	—	-6.2	-5.24	-4.05	-1.66
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.579	0.3	0	—	2.17
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	0.579	-5.9	-5.24	-4.05	0.514
Financing Cash Flow Items	—	97.9	26.8	20.1	5.54
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	—	98.6	120	24.1	6.7
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.602	-17.4	-23.3	-18.6	0.814